Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia

Molecular Metabolism

Volumn 5, Issue 6, 2016, Pages 392-403

  Pomié, Céline ^a,b   Blasco Baque, Vincent ^a,b   Klopp, Pascale ^a,b   Nicolas, Simon ^a,b   Waget, Aurélie ^a,b   Loubières, Pascale ^a,b   Azalbert, Vincent ^a,b   Puel, Anthony ^a,b   Lopez, Frédéric ^d   Dray, Cédric ^b   Valet, Philippe ^b   Lelouvier, Benjamin ^c   Servant, Florence ^c   Courtney, Michael ^c   Amar, Jacques ^a,b   Burcelin, Rémy ^a,b   Garidou, Lucile ^a,b  

^a INSERM   (France)

^b Université de Toulouse   (France)

^c VAIOMER SAS   (France)

^d CANCER RESEARCH CENTER OF TOULOUSE   (France)

Author keywords

Gut microbiota and metabolic diseases; Immunity; Insulin resistance

Indexed keywords

BACTERIAL EXTRACT; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; SECONDARY LYMPHOID TISSUE CHEMOKINE; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BETAPROTEOBACTERIA; BURKHOLDERIACEAE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DOSE RESPONSE; DYSBIOSIS; DYSGLYCEMIA; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; ILEUM; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPETENT CELL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINAL ILEUM; INTESTINE FLORA; LIPID DIET; LYMPHOCYTE PROLIFERATION; LYMPHOID ORGAN; METABOLIC DISORDER; METABOLISM; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PEPTOSTREPTOCOCCACEAE; PHYLLOBACTERIACEAE; PORPHYROMONADACAEA; PRIORITY JOURNAL; SPHINGOMONADACEAE; SUTTERELLACEAE;

EID: 84962597558     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2016.03.004     Document Type: Article

References (38)

1. Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490:55-60.
2. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
3. Velagapudi V.R., Hezaveh R., Reigstad C.S., Gopalacharyulu P., Yetukuri L., Islam S., et al. The gut microbiota modulates host energy and lipid metabolism in mice. Journal of Lipid Research 2010, 51:1101-1112.
4. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
5. Garidou L., Pomie C., Klopp P., Waget A., Charpentier J., Aloulou M., et al. The gut microbiota regulates intestinal CD4 T cells expressing RORgammat and controls metabolic disease. Cell Metabolism 2015, 22:100-112.
6. Dumas M.E., Barton R.H., Toye A., Cloarec O., Blancher C., Rothwell A., et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proceedings of the National Academy of Sciences U S A 2006, 103:12511-12516.
7. Karlsson F.H., Fak F., Nookaew I., Tremaroli V., Fagerberg B., Petranovic D., et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nature Communication 2012, 3:1245.
8. Tremaroli V., Karlsson F., Werling M., Stahlman M., Kovatcheva-Datchary P., Olbers T., et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metabolism 2015, 22:228-238.
9. Caesar R., Tremaroli V., Kovatcheva-Datchary P., Cani P.D., Backhed F. Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metabolism 2015.
10. Hooper L.V., Gordon J.I. Commensal host-bacterial relationships in the gut. Science 2001, 292:1115-1118.
11. Sommer F., Backhed F. The gut microbiota - masters of host development and physiology. Nature Reviews and Microbiology 2013.
12. Gaboriau-Routhiau V., Rakotobe S., Lecuyer E., Mulder I., Lan A., Bridonneau C., et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009, 31:677-689.
13. Ivanov, Atarashi K., Manel N., Brodie E.L., Shima T., Karaoz U., et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139:485-498.
14. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
15. Round J.L., Mazmanian S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proceedings of the National Academy of Sciences U S A 2010, 107:12204-12209.
16. Mowat A.M., Agace W.W. Regional specialization within the intestinal immune system. Nature Reviews and Immunology 2014, 14:667-685.
17. Suzuki K., Ha S.A., Tsuji M., Fagarasan S. Intestinal IgA synthesis: a primitive form of adaptive immunity that regulates microbial communities in the gut. Seminars in Immunology 2007, 19:127-135.
18. Wichner K., Fischer A., Winter S., Tetzlaff S., Heimesaat M.M., Bereswill S., et al. Transition from an autoimmune-prone state to fatal autoimmune disease in CCR7 and RORgammat double-deficient mice is dependent on gut microbiota. Journal of Autoimmunity 2013, 47:58-72.
19. Medina-Contreras O., Geem D., Laur O., Williams I.R., Lira S.A., Nusrat A., et al. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. Journal of Clinical Investigation 2011, 121:4787-4795.
20. Caricilli A.M., Picardi P.K., de Abreu L.L., Ueno M., Prada P.O., Ropelle E.R., et al. Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biology 2011, 9:e1001212.
21. Albenberg L., Esipova T.V., Judge C.P., Bittinger K., Chen J., Laughlin A., et al. Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology 2014, 147:1055-1063. e8.
22. Amar J., Chabo C., Waget A., Klopp P., Vachoux C., Bermudez-Humaran L.G., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Molecular Medicine 2011, 3:559-572.
23. Burcelin R., Crivelli V., Dacosta A., Roy-Tirelli A., Thorens B. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. American Journal of Physiology, Endocrinology and Metabolism 2002, 282:E834-E842.
24. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
25. Burcelin R., Uldry M., Foretz M., Perrin C., Dacosta A., Nenniger-Tosato M., et al. Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype. Journal of Biological Chemistry 2004, 279:1108-1115.
26. Garidou L., Heydari S., Truong P., Brooks D.G., McGavern D.B. Therapeutic memory T cells require costimulation for effective clearance of a persistent viral infection. Journal of Virology 2009, 83:8905-8915.
27. Garidou L., Heydari S., Gossa S., McGavern D.B. Therapeutic blockade of transforming growth factor beta fails to promote clearance of a persistent viral infection. Journal of Virology 2012, 86:7060-7071.
28. Amar J., Burcelin R., Ruidavets J.B., Cani P.D., Fauvel J., Alessi M.C., et al. Energy intake is associated with endotoxemia in apparently healthy men. American Journal of Clinical Nutrition 2008, 87:1219-1223.
29. Grewal H.M., Karlsen T.H., Vetvik H., Ahren C., Gjessing H.K., Sommerfelt H., et al. Measurement of specific IgA in faecal extracts and intestinal lavage fluid for monitoring of mucosal immune responses. Journal of Immunological Methods 2000, 239:53-62.
30. Abdul-Ghani M., DeFronzo R.A. Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion. Journal of Clinical Endocrinology and Metabolism 2007, 92:1778-1784.
31. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
32. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. Journal of Clinical Investigation 2006, 116:1793-1801.
33. Luck H., Tsai S., Chung J., Clemente-Casares X., Ghazarian M., Revelo X.S., et al. Regulation of obesity-related insulin resistance with gut anti-inflammatory agents. Cell Metabolism 2015, 21:527-542.
34. Moskophidis D., Lechner F., Pircher H., Zinkernagel R.M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993, 362:758-761.
35. Fazilleau N., McHeyzer-Williams L.J., Rosen H., McHeyzer-Williams M.G. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nature Immunology 2009, 10:375-384.
36. Macpherson A.J., Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303:1662-1665.
37. Garrett W.S., Gallini C.A., Yatsunenko T., Michaud M., DuBois A., Delaney M.L., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host and Microbe 2010, 8:292-300.
38. Koren O., Spor A., Felin J., Fak F., Stombaugh J., Tremaroli V., et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proceedings of the National Academy of Sciences U S A 2011, 108(Suppl. 1):4592-4598.